|
Index of reports
> Cases with Neutropenia (70)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neupogen (Filgrastim) where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 70 Next >>
Possible Neupogen side effects in 59 year old female
Reported by a physician from United States on 2012-08-20
Patient: 59 year old female, weighing 58.9 kg (129.6 pounds)
Reactions: White Blood Cell Count Decreased, Blood Bilirubin Increased, Jaundice, Hepatic Function Abnormal, Haematuria, Alanine Aminotransferase Increased, Cystitis, Fatigue, Diarrhoea, Aspartate Aminotransferase Increased, Platelet Count Decreased, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sorafenib
Dosage: unk, 2 cycles
Indication: Acute Myeloid Leukaemia
Fluconazole
Dosage: unk
Indication: Antifungal Treatment
End date: 2012-07-24
Mozobil
Dosage: unk, 2 cycles
Indication: Acute Myeloid Leukaemia
Neupogen
Dosage: unk, 2 cycles
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Antibacterial NOS; Antivirals NOS
Possible Neupogen side effects in 58 year old male
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient: 58 year old male
Reactions: White Blood Cell Count Decreased, Tooth Loss, Stomatitis, Therapeutic Response Decreased, Cheilitis, Fatigue, Neutropenia, Sluggishness, Asthenia, Feeling Abnormal, Medical Device Discomfort
Drug(s) suspected as cause:
Neupogen
Possible Neupogen side effects in 50 year old male
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient: 50 year old male
Reactions: Injection Site Haemorrhage, Neutropenia
Drug(s) suspected as cause:
Neupogen
Possible Neupogen side effects in 82 year old female
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient: 82 year old female
Reactions: Urticaria, Neutropenia, Rash
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, q3wk
Indication: Breast Cancer
Start date: 2012-01-04
End date: 2012-02-01
Neupogen
Indication: Breast Cancer
Start date: 2012-03-08
Other drugs received by patient: Dexamethasone; Cytoxan; Enalapril Maleate; Metoprolol Tartrate; Taxotere
Possible Neupogen side effects in 25 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient: 25 year old female
Reactions: Neutropenia
Drug(s) suspected as cause:
Neupogen
Possible Neupogen side effects in 64 year old male
Reported by a physician from Malaysia on 2012-08-14
Patient: 64 year old male, weighing 53.0 kg (116.6 pounds)
Reactions: Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Other drugs received by patient: Docetaxel
Possible Neupogen side effects in female
Reported by a health professional (non-physician/pharmacist) from Finland on 2012-07-31
Patient: female
Reactions: Retinal Disorder, Rash, Neutropenia
Drug(s) suspected as cause:
Neupogen
Dosage: unk
Indication: Neutropenia
Copegus
Dosage: unk
Indication: Hepatitis C
Rebetol
Dosage: unk
Indication: Hepatitis C
Pegasys
Dosage: unk
Indication: Hepatitis C
Possible Neupogen side effects in 45 year old female
Reported by a pharmacist from Malaysia on 2012-07-30
Patient: 45 year old female, weighing 41.0 kg (90.2 pounds)
Reactions: Neutropenia
Drug(s) suspected as cause:
Neupogen
Other drugs received by patient: Gemcitabine; Cisplatin
Possible Neupogen side effects in 41 year old female
Reported by a pharmacist from Malaysia on 2012-07-27
Patient: 41 year old female
Reactions: Sepsis, Neutropenia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Other drugs received by patient: Adriamycin / 00330902 /; Cyclophosphamide
Possible Neupogen side effects in
Reported by a physician from Japan on 2012-07-17
Patient:
Reactions: Neuropathy Peripheral, Interstitial Lung Disease, Neutropenia, Infection
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: B-Cell Lymphoma
Rituxan
Dosage: 6 doses-2 days prior to each cycle of chop
Indication: B-Cell Lymphoma
Prednisolone
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Cyclophosphamide
Indication: B-Cell Lymphoma
Neupogen
Indication: B-Cell Lymphoma
Possible Neupogen side effects in
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-05
Patient:
Reactions: Neuropathy Peripheral, Interstitial Lung Disease, Neutropenia, Infection
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Doxorubicin HCL
Indication: B-Cell Lymphoma
Rituximab
Dosage: 6 doses-2 days prior to each cycle of chop
Indication: B-Cell Lymphoma
Neupogen
Indication: B-Cell Lymphoma
Prednisolone
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Possible Neupogen side effects in 45 year old female
Reported by a pharmacist from Malaysia on 2012-06-29
Patient: 45 year old female, weighing 41.0 kg (90.2 pounds)
Reactions: Neutropenia
Drug(s) suspected as cause:
Neupogen
Other drugs received by patient: Gemcitabine; Cisplatin
Possible Neupogen side effects in 64 year old male
Reported by a physician from Malaysia on 2012-06-29
Patient: 64 year old male, weighing 53.0 kg (116.6 pounds)
Reactions: Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Other drugs received by patient: Docetaxel
Possible Neupogen side effects in 76 year old female
Reported by a pharmacist from Canada on 2012-06-29
Patient: 76 year old female
Reactions: Neutropenia, Leukocytosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: unk
Indication: Neutropenia
Start date: 2012-06-18
End date: 2012-06-22
Neupogen
Indication: Chemotherapy
Other drugs received by patient: Doxorubicin HCL; Cyclophosphamide; Vincristine; Rituximab; Prednisolone
Possible Neupogen side effects in 41 year old
Reported by a pharmacist from Malaysia on 2012-06-28
Patient: 41 year old
Reactions: Sepsis, Neutropenia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Other drugs received by patient: Adriamycin / 00330902 /; Cyclophosphamide
Possible Neupogen side effects in 64 year old male
Reported by a pharmacist from Malaysia on 2012-06-22
Patient: 64 year old male, weighing 53.0 kg (116.6 pounds)
Reactions: Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Other drugs received by patient: Docetaxel
Possible Neupogen side effects in 20 year old female
Reported by a physician from United States on 2012-06-13
Patient: 20 year old female, weighing 74.4 kg (163.6 pounds)
Reactions: Caesarean Section, Furuncle, Skin Infection, Neutropenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: 300 mug, bid
Indication: Infantile Genetic Agranulocytosis
Start date: 1991-01-01
Neupogen
Dosage: 300 mug, bid
Start date: 2011-10-27
Possible Neupogen side effects in female
Reported by a physician from United States on 2012-06-12
Patient: female, weighing 2.7 kg (5.9 pounds)
Reactions: Caesarean Section, Maternal Drugs Affecting Foetus, Neutropenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Other drugs received by patient: Antibiotics
Possible Neupogen side effects in 18 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-28
Patient: 18 year old female
Reactions: Oligohydramnios, Normal Newborn, Anaemia, Febrile Neutropenia, Neutropenia, Pregnancy, Thrombocytopenia
Drug(s) suspected as cause:
Neupogen
Indication: Rhabdomyosarcoma
Dactinomycin
Dosage: q21d
Indication: Rhabdomyosarcoma
Vincristine
Indication: Rhabdomyosarcoma
Cyclophosphamide
Dosage: 1 df: 2.2g/m2
Indication: Rhabdomyosarcoma
Mesna
Indication: Rhabdomyosarcoma
Possible Neupogen side effects in 70 year old female
Reported by a physician from Germany on 2012-05-14
Patient: 70 year old female, weighing 88.0 kg (193.6 pounds)
Reactions: Neutropenia, Leukopenia
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk
Indication: Prophylaxis
Start date: 2012-02-16
Neupogen
Indication: Neutropenia
Other drugs received by patient: Cyclophosphamide; Epirubicin
Possible Neupogen side effects in
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-25
Patient:
Reactions: Vomiting, Nausea, Cardiac Disorder, Death, Mucosal Inflammation, Neutropenia, non-Hodgkin's Lymphoma, Thrombocytopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Possible Neupogen side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-25
Patient:
Reactions: Stomatitis, Nausea, Anaemia, General Physical Health Deterioration, Toxicity To Various Agents, Disease Progression, Fatigue, Alopecia, Adverse Event, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
TH-302
Indication: Sarcoma
Doxorubicin HCL
Indication: Sarcoma
Neupogen
Indication: Sarcoma
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-24
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-12-02
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Administration route: Oral
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Citalopram Hydrobromide; Pirenzepine; Amisulpride
Possible Neupogen side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-18
Patient: female
Reactions: Thrombosis, Agitation, Hepatic Failure, Headache, Peripheral Sensory Neuropathy, Malaise, Granulocytopenia, Stomatitis, Anaemia, Hyperglycaemia, Intestinal Obstruction, Neutropenia, Bone Pain, Pain, Gastrointestinal Inflammation, Constipation, Hypokalaemia, Fatigue, Depression, Thrombocytopenia, Pharyngitis, Lethargy, Decreased Appetite, Dyspnoea, Vomiting, Nausea, Lymphopenia, Hyponatraemia, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Anxiety, Syncope, Diarrhoea, Embolism, Leukopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Paclitaxel
Indication: Breast Cancer
Doxorubicin HCL
Dosage: 60 mg/m2 for standard arm and 24 mg/m2 for continuous arm
Indication: Breast Cancer
Cyclophosphamide
Indication: Breast Cancer
Neupogen
Indication: Palliative Care
Cyclophosphamide
Administration route: Oral
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-03
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-30
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Agranulocytosis, Sepsis, Neutropenia, Deep Vein Thrombosis, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 110 mg milligram(s),intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Dosage: 1600 mg milligram(s)intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg milligram(s)intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Vincristine Sulfate
Dosage: 2 mg milligram(s), intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg milligram(s)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg milligram(s) ( 1 day ) oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Clozapine
Dosage: 200 mg milligram(s) ( 1 day ) oral
Indication: Schizophrenia
Start date: 2011-12-02
Other drugs received by patient: Citalopram Hydrobromide
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-27
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Amisulpride; Pirenzepine; Citalopram
Possible Neupogen side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-20
Patient: 44 year old female
Reactions: Fluid Overload, Vomiting, Nausea, International Normalised Ratio Increased, Pyrexia, Hypernatraemia, Lobar Pneumonia, Mucosal Inflammation, Diarrhoea, Neutropenia
Drug(s) suspected as cause:
Neupogen
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-09
End date: 2011-10-16
Melphalan Hydrochloride
Indication: Bone Marrow Transplant
Start date: 2011-10-01
End date: 2011-10-02
Other drugs received by patient: Bactrim; Acyclovir; Folic Acid; Klonopin; Lithium Carbonate; Magnesium; Multi-Vitamin; Haldol; Paxil; Depakote; Geodon
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-20
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutrophil Count Increased, Neutropenia, Deep Vein Thrombosis, White Blood Cell Count Increased, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 60 mg mgilligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Vincristine Sulfate
Dosage: 2 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Dosage: 1600 mgilligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg mgilligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Citalopram Hydrobromide; (Amisulpride); (Pirenzepine)
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-15
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Amisulpride; Pirenzepine; Citalopram
Page 1 Next >>
|
